These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7794256)

  • 1. Leucine zipper-like domain regulates the autophosphorylation and the transforming activity of P130gag-fps.
    Park WY; Seo JS
    Biochem Biophys Res Commun; 1995 Jun; 211(2):447-53. PubMed ID: 7794256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity.
    Moran MF; Koch CA; Sadowski I; Pawson T
    Oncogene; 1988 Dec; 3(6):665-72. PubMed ID: 2577868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.
    Sadowski I; Stone JC; Pawson T
    Mol Cell Biol; 1986 Dec; 6(12):4396-408. PubMed ID: 3025655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.
    Koch CA; Moran M; Sadowski I; Pawson T
    Mol Cell Biol; 1989 Oct; 9(10):4131-40. PubMed ID: 2685548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of Fujinami sarcoma virus: evidence that tyrosine phosphorylation of P130gag-fps modulates its biological activity.
    Weinmaster G; Zoller MJ; Smith M; Hinze E; Pawson T
    Cell; 1984 Jun; 37(2):559-68. PubMed ID: 6327076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major site of tyrosine phosphorylation within the SH2 domain of Fujinami sarcoma virus P130gag-fps is not required for protein-tyrosine kinase activity or transforming potential.
    Weinmaster GA; Middlemas DS; Hunter T
    J Virol; 1988 Jun; 62(6):2016-25. PubMed ID: 2452898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic and non-catalytic domains of the Fujinami sarcoma virus P130gag-fps protein-tyrosine kinase distinguished by the expression of v-fps polypeptides in Escherichia coli.
    Sadowski I; Pawson T
    Oncogene; 1987 May; 1(2):181-91. PubMed ID: 2449646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity.
    Weinmaster G; Zoller MJ; Pawson T
    EMBO J; 1986 Jan; 5(1):69-76. PubMed ID: 3007119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-fps causes transformation by inducing tyrosine phosphorylation and activation of the PDGFbeta receptor.
    Anderson DH; Ismail PM
    Oncogene; 1998 May; 16(18):2321-31. PubMed ID: 9620549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic activation of Fujinami sarcoma virus gag-fps transforming proteins by autophosphorylation at tyrosine.
    Meckling-Hansen K; Nelson R; Branton P; Pawson T
    EMBO J; 1987 Mar; 6(3):659-66. PubMed ID: 3034604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the role of P130gag-fps in transformation: generation and use of a temperature-sensitive mutant P130gag-fps.
    Weinmaster GA; Hunter T
    J Virol; 1988 Oct; 62(10):3849-54. PubMed ID: 2843679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase activity of FSV (Fujinami sarcoma virus) P130gag-fps shows a strict specificity for tyrosine residues.
    Weinmaster G; Pawson T
    J Biol Chem; 1986 Jan; 261(1):328-33. PubMed ID: 3510199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell.
    DeClue JE; Sadowski I; Martin GS; Pawson T
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9064-8. PubMed ID: 3480531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of host-dependent src kinase activity by co-expression with a heterologous tyrosine kinase.
    Liebl EC; England LJ; Martin GS
    Virology; 1993 Jul; 195(1):265-7. PubMed ID: 8317103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications of tumor histology by point mutations in the v-fps oncogene: possible role of extracellular matrix.
    Auersperg N; Pawson T; Worth A; Weinmaster G
    Cancer Res; 1987 Dec; 47(23):6341-8. PubMed ID: 3315185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions in leucine zipper motif in the F-specific domain of human parainfluenza virus 3 HN protein play important roles in the protein function.
    Zhang W; Ren G; Wu B; Liu X; Wang G; Song Y; Xu H; Wen H; Wang Z
    Intervirology; 2008; 51(5):311-21. PubMed ID: 19018146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.